132 related articles for article (PubMed ID: 38159864)
1. TMEM2 inhibits the development of Graves' orbitopathy through the JAK-STAT signaling pathway.
Li H; Min J; Yang Y; Suo W; Wang W; Tian J; Qin Y
J Biol Chem; 2024 Feb; 300(2):105607. PubMed ID: 38159864
[TBL] [Abstract][Full Text] [Related]
2. Disulfiram Exerts Antiadipogenic, Anti-Inflammatory, and Antifibrotic Therapeutic Effects in an
Wang X; Yang S; Ye H; Chen J; Shi L; Feng L; Wang X; Zhang T; Chen R; Xiao W; Yang H
Thyroid; 2022 Mar; 32(3):294-305. PubMed ID: 34605662
[No Abstract] [Full Text] [Related]
3. PERK mediates oxidative stress and adipogenesis in Graves' orbitopathy pathogenesis.
Ko J; Kim JY; Kyoung Chae M; Jig Lee E; Sook Yoon J
J Mol Endocrinol; 2021 May; 66(4):313-323. PubMed ID: 33870911
[TBL] [Abstract][Full Text] [Related]
4. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS
Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522
[TBL] [Abstract][Full Text] [Related]
5. Anti-oxidative and anti-adipogenic effects of caffeine in an in vitro model of Graves' orbitopathy.
Ko J; Kim JY; Kim JW; Yoon JS
Endocr J; 2020 Apr; 67(4):439-447. PubMed ID: 31941844
[TBL] [Abstract][Full Text] [Related]
6. A Promising Mouse Model of Graves' Orbitopathy Induced by Adenovirus Expressing Thyrotropin Receptor A Subunit.
Zhang M; Ding X; Wu LP; He MQ; Chen ZY; Shi BY; Wang Y
Thyroid; 2021 Apr; 31(4):638-648. PubMed ID: 33076782
[No Abstract] [Full Text] [Related]
7. Neferine suppresses autophagy-induced inflammation, oxidative stress and adipocyte differentiation in Graves' orbitopathy.
Li H; Gao L; Min J; Yang Y; Zhang R
J Cell Mol Med; 2021 Feb; 25(4):1949-1957. PubMed ID: 33443817
[TBL] [Abstract][Full Text] [Related]
8. Human placenta-derived mesenchymal stem cells ameliorate orbital adipogenesis in female mice models of Graves' ophthalmopathy.
Park M; Banga JP; Kim GJ; Kim M; Lew H
Stem Cell Res Ther; 2019 Aug; 10(1):246. PubMed ID: 31399042
[TBL] [Abstract][Full Text] [Related]
9. Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts.
Guo Y; Li H; Chen X; Yang H; Guan H; He X; Chen Y; Pokharel S; Xiao H; Li Y
J Clin Endocrinol Metab; 2020 Jun; 105(6):1906-17. PubMed ID: 32249902
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Effect of Resveratrol on Oxidative Stress in Graves' Orbitopathy Orbital Fibroblasts.
Kim CY; Lee HJ; Chae MK; Byun JW; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6352-61. PubMed ID: 26436888
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic Phenotype of Adipogenesis and Hyaluronan in Orbital Fibroblasts From Female Graves' Orbitopathy Mouse Model.
Görtz GE; Moshkelgosha S; Jesenek C; Edelmann B; Horstmann M; Banga JP; Eckstein A; Berchner-Pfannschmidt U
Endocrinology; 2016 Oct; 157(10):3771-3778. PubMed ID: 27552248
[TBL] [Abstract][Full Text] [Related]
12. Polydatin attenuates orbital oxidative stress in Graves' orbitopathy through the NRF2 pathway.
Li H; Min J; Chen Y; Li H; Zhang Y
Chem Biol Interact; 2020 Jan; 315():108894. PubMed ID: 31705858
[TBL] [Abstract][Full Text] [Related]
13. Wnt signalling inhibits adipogenesis in orbital fibroblasts from patients with Graves' orbitopathy.
Jung SJ; Choi YJ; Park TK; Woo SE; Kim BY; Yoon JS; Jang SY
Br J Ophthalmol; 2022 Jul; 106(7):1019-1027. PubMed ID: 34193409
[TBL] [Abstract][Full Text] [Related]
14. The Role of Sphingosine-1-Phosphate in Adipogenesis of Graves' Orbitopathy.
Kim SE; Lee JH; Chae MK; Lee EJ; Yoon JS
Invest Ophthalmol Vis Sci; 2016 Feb; 57(2):301-11. PubMed ID: 26830367
[TBL] [Abstract][Full Text] [Related]
15. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
[TBL] [Abstract][Full Text] [Related]
16. Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy.
Ko J; Kim YJ; Choi SH; Lee CS; Yoon JS
Thyroid; 2023 Dec; 33(12):1465-1475. PubMed ID: 37800725
[No Abstract] [Full Text] [Related]
17. PRL-1 overexpressed placenta-derived mesenchymal stem cells suppress adipogenesis in Graves' ophthalmopathy through SREBP2/HMGCR pathway.
Park M; Kim JY; Kang JM; Lee HJ; Banga JP; Kim GJ; Lew H
Stem Cell Res Ther; 2021 May; 12(1):304. PubMed ID: 34051850
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic Potential of Targeting Periostin in the Treatment of Graves' Orbitopathy.
Jang SY; Kim J; Park JT; Liu CY; Korn BS; Kikkawa DO; Lee EJ; Yoon JS
Front Endocrinol (Lausanne); 2022; 13():900791. PubMed ID: 35707463
[TBL] [Abstract][Full Text] [Related]
19. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.
Byeon HJ; Chae MK; Ko J; Lee EJ; Kikkawa DO; Jang SY; Yoon JS
Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):13. PubMed ID: 37555734
[TBL] [Abstract][Full Text] [Related]
20. Role of binding immunoglobulin protein (BiP) in Graves' orbitopathy pathogenesis.
Ko J; Kim JY; Lee EJ; Yoon JS
J Mol Endocrinol; 2021 Jan; 66(1):71-81. PubMed ID: 33112798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
